Increased Serum Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels in FSGS: A Meta-Analysis

INTRODUCTION: The soluble urokinase-type plasminogen activator receptor (suPAR) has been found to be elevated in primary focal segmental glomerulosclerosis (pFSGS). However, its usefulness as a biomarker for FSGS remains controversial. We conducted a meta-analysis aiming at investigating the signifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jiwon M., Yang, Jae Won, Kronbichler, Andreas, Eisenhut, Michael, Kim, Gaeun, Lee, Keum Hwa, Shin, Jae Il
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476117/
https://www.ncbi.nlm.nih.gov/pubmed/31089477
http://dx.doi.org/10.1155/2019/5679518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476117/
https://www.ncbi.nlm.nih.gov/pubmed/31089477
http://dx.doi.org/10.1155/2019/5679518

Ejemplares similares